复发性前列腺癌立体定向再照射中可实现的剂量学约束
该回顾性剂量学分析纳入141例接受射波刀治疗的复发性前列腺癌患者,按GETUG-31试验剂量体积约束评估。仅19%患者满足全部约束,靶区覆盖和危及器官保护随靶区体积增大而显著下降,作者针对大靶区提出了新的剂量体积约束。
要点
- 仅19%患者满足GETUG-31全部剂量体积约束,其平均PTV为18.5 cc(范围3-48 cc)。
- CTV/前列腺比值>0.5的患者中98%无法满足危及器官剂量体积约束。
- 作者提出大靶区时直肠V12Gy<25%、V27Gy<2 cc,膀胱V12Gy<25%、V27Gy<5 cc的新约束。
核心结论
- GETUG-31剂量体积约束仅适用于小靶区(CTV超过前列腺一半),大靶区需采用作者提出的新剂量体积约束。
研究设计与样本
- 回顾性剂量学分析,纳入141例接受射波刀治疗的复发性前列腺癌患者,按GETUG-31试验约束评估。
主要发现
- 仅19%患者满足全部剂量体积约束,其平均PTV为18.5 cc(范围3-48 cc),而全系列平均PTV为40.5 cc(范围3-174 cc)。
- CTV/前列腺比值>0.5的患者中98%无法满足危及器官剂量体积约束。
- 靶区覆盖和危及器官保护随PTV、CTV、CTV/前列腺比值、PTV与膀胱壁及直肠壁重叠体积增大而显著下降。
- PTV阈值>20 cc和40 cc分别允许满足PTV和膀胱剂量体积约束。
关键数值与推荐
- GETUG-31约束:PTV V95%≥95%,直肠V12Gy<20%且V27Gy<2 cc,膀胱V12Gy<15%且V27Gy<5 cc。
- 作者提出的新约束:直肠V12Gy<25%且V27Gy<2 cc,膀胱V12Gy<25%且V27Gy<5 cc。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Stereotactic body radiation therapy has been proposed as a salvage treatment for recurrent prostate cancer after irradiation. One crucial issue is choosing appropriate dose-volume constraints (DVCs) during planning. The objectives of this study were to (1) quantify the proportion of patients respecting the DVCs according to the Urogenital Tumor Study Group GETUG-31 trial, testing 36 Gy in six fractions, (2) explain geometrically why the DVCs could not be respected, and (3) propose the most suitable DVCs. METHODS AND MATERIALS: This retrospective dosimetric analysis included 141 patients treated for recurrent prostate cancer with Cyberknife (Accuray), according to GETUG-31 DVCs: V95% ≥ 95% for the planning target volume (PTV), V12Gy < 20% and V27Gy < 2 cc for the rectum, and V12Gy < 15% and V27Gy < 5 cc for the bladder. The percentage of patients not respecting the DVCs was quantified. Correlations between the DVCs and anatomic structures were examined. New DVCs were proposed. RESULTS: Only 19% of patients respected all DVCs, with a mean PTV of 18.5 cc (range, 3-48 cc), although the mean PTV was 40.5 cc (range, 3-174 cc) in the whole series. A total of 98% of the patients with a clinical target volume (CTV)/prostate ratio >0.5 could not respect the DVCs in the organs at risk. The target coverage and organ-at-risk sparing decreased significantly with increase in the values of PTV, CTV, CTV/prostate ratio, the overlapping volume between the PTV and bladder wall and between the PTV and rectal wall. Threshold values of PTV, >20 cc and 40 cc, allowed for the PTV and bladder DVCs, respectively. To improve DVC respect in case of large target volume, we proposed the following new DVCs: V12Gy < 25% and 25% and V27Gy < 2 cc and 5 cc for the rectum and bladder, respectively. CONCLUSIONS: GETUG-31 DVCs are achievable only for small target volumes (CTV more than half of the prostate). For a larger target volume, new DVCs have been proposed.
引用
- Baty M, Pasquier D, Gnep K, et al. Achievable Dosimetric Constraints in Stereotactic Reirradiation for Recurrent Prostate Cancer. Pract Radiat Oncol. 2023. PMID: 37295723. doi:10.1016/j.prro.2023.05.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。